Apnimed was founded in 2017 and is located in Cambridge, MA. We are a clinical-stage company dedicated to the discovery of novel pharmacologic therapies for sleep apnea and related disorders.

Managers

Ron Farkas, M.D.,Ph.D.
Chief Medical Officer

Larry Miller, M.D.
Chief Executive Officer

Dennis Molnar
Chief Operating Officer

Barry Wohl
Chief Business Officer

Board of Directors

Joe Avellone, M.D.

Gerald Chan, Sc.D.
Morningside

Ronnie Farquhar, Ph.D.
Morningside

Larry Miller, M.D., CEO
Apnimed

Dennis Molnar, COO
Apnimed

Advisory Board

Danny Eckert, Ph.D., Chair
Flinders Univ.
Univ. of New South Wales

John W. Cronin, M.D.
Scripps Health

Diane Lim, M.D.
University of Pennsylvania

Carlos M. Nunez, M.D.
ResMed Corp

Naresh Punjabi, M.D., Ph.D.
Johns Hopkins University

Alan Schwartz, M.D.
Johns Hopkins University, emeritus

Luigi Taranto, M.D.
Harvard Medical School
Apnimed

Andrew Wellman, M.D., Ph.D.
Harvard Medical School